Navigation Links
Third Wave reports net loss of $18.9M for 2006

Madison, Wis. - Third Wave Technologies reported a smaller net loss of $18.9 million, or 45 cents per share in 2006, but the company experienced impressive growth in clinical molecular diagnostic revenue, according to a year-end financial report.

Third Wave, which develops molecular diagnostic products for use in clinical testing, said its $18.9 mil......

Full article >>> litigation will cause operating expenses to increase in 2007.

......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 02/22/07


Related biology technology :

1. Third Wave files countersuit vs. Digene in patent case
2. Stratagene to pay Third Wave $10.75M in patent case
3. Third Wave responds to Digene patent lawsuit
4. Third Wave seeks approval of Cystic Fibrosis test
5. Third Wave Technologies to raise $14.9M through private debt
6. Third Wave reports $5.2M third quarter loss
7. Third Wave reports another loss, stronger sales
8. Napier joins board of Third Wave Technologies
9. Third Waves revenues rebound
10. Third Wave reports clinical growth, continued loss
11. Third Wave announces two senior management appointments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... 22, 2017  PrimeVax Immuno-Oncology, Inc. announced today its ... the Annual Biocom Global Life Science Partnering Conference.  The ... AM, at the Torrey Pines Lodge, in San Diego.  ... at Biocom who have chosen our company, amongst numerous ... companies, investors, and clinical researchers," said Mr. Chen. "In ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... and development of precision treatments for neurodegenerative diseases, today announced it has issued ... ProMIS approach.” This is one of a series of commentaries from ProMIS’s scientific ...
(Date:2/22/2017)... , Feb 22, 2017 Dublin ... the "Global Biological Crop Protection (Bio-Pesticide) Market-By Type, By Application, ... report to their offering. ... Global Biological Crop Protection Market is forecasted to ... The strong growth in biopesticide or biological crop protection market is ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... Spyker, PhD, MD former Acting Deputy Director in the FDA CDRH Division of ... Staff has joined the company as an Expert Consultant. , In Dr. Spyker’s ...
Breaking Biology Technology:
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
Breaking Biology News(10 mins):